Is Intuitive Surgical Stock a Buy Now?

Robotic-surgery leader Intuitive Surgical‘s (NASDAQ: ISRG) stock has been an incredible long-term winner. Since its initial public offering (IPO) in 2000, share prices are up over 10,800% — a testament to investing in industry disruptors that also improve the world. 

However, Intuitive Surgical’s results have been a bit more inconsistent in recent years. Competition for robotic surgery is heating up, but the biggest hurdle here has been the pandemic. Growth in the second quarter of 2022 slowed to a trickle as the company tries to navigate supply chain and COVID-19 surgery restrictions in some markets. It remains an industry leader, but is Intuitive Surgical a buy now?

Slowing growth from supply chain issues

Intuitive Surgical’s stock has been in free fall in 2022. The price has dipped nearly 40% year to date with just a week left in July, perpetuated by slowing growth. 

Q2 2022 was a disappointment, with revenue increasing only 4%. The reason? Only 279 da Vinci surgery systems were placed in the last three months, compared with 328 in the same period a year ago. Additionally, of the 279 systems placed, 117 of them (or 42% of the total) were sold on an operating-lease or usage-based agreement — compared to just 33% of total systems placed a year ago on an operating-lease or usage-based agreement. As a reminder, Intuitive realizes revenue from this type of placement over time, versus a larger upfront payment for an outright sale. 

A few months ago, management warned that supply chain issues (specifically, not obtaining enough components to build machines), inflation in shipping costs, and COVID-19 lockdowns in some markets were going to hurt system placement in Q2. While it was more severe than expected, the good news is that Intuitive’s total installed base of da Vinci systems is still on the rise.

More importantly, demand for robotic-assisted surgery is also increasing. System-placement sales are now down year over year through the first half of 2022, but ongoing sales of instruments and services are steadily growing. 

Segment Revenue

First Half 2022

YOY Increase (Decrease)

System placements

$803 million


Instruments and accessories

$1.71 billion



$501 million


Total revenue

$3.01 billion


Data source: Intuitive Surgical. YOY = year over year.

A high price for good reason

There are a few upshots to the Q2 letdown. First, revenue growth could accelerate in 2023 because this current year is setting such a low bar to clear. As Intuitive laps its depressed number of da Vinci system placements next year, revenue expansion could be rekindled. 

Intuitive Surgical’s profitability (as measured by earnings per share and free cash flow per share) has also dipped from its all-time peak last summer. The company is constantly investing in new system innovations to increase the number of procedures surgeons can perform. Over time, I expect profitability to also make a recovery and help Intuitive’s stock return to its market-beating ways.

Data by YCharts.

Finally, there’s the balance sheet, which had $8.18 billion in cash and investments and zero debt as of the end of June 2022. This is an exceptionally strong healthcare technologist built for long-term profitable growth. 

After selling off hard this year, Intuitive Surgical stock trades for 47 times enterprise value to free cash flow. It’s the cheapest valuation of the company since the pandemic started, but it’s still a premium price tag that assumes the company will be a steadily growing business for the foreseeable future. 

Intuitive Surgical has a long runway of growth ahead (most surgeries around the world are still performed without any robotic assistance), and it’s still early on in its transition to a “value stock” ($500 million worth of shares were repurchased last quarter). Given this, I’m still in accumulation mode. If you decide to buy, remember to start small and make the stock part of a well-diversified portfolio that includes shares of other healthcare companies and stocks from other sectors of the economy.

Nicholas Rossolillo and his clients have positions in Intuitive Surgical. The Motley Fool has positions in and recommends Intuitive Surgical. The Motley Fool has a disclosure policy.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

  • This field is for validation purposes and should be left unchanged.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Rebate Rewards

Level 2 Rebate

Deposit $2,000 and get $200 Rebate
$ 200 Rebate
  • 3 Simple Steps
  • 1. Register Using The Link Below (Promo-Code: WEBREBATE)
  • 2. Deposit $2,000 and place one trade at any non-Austalian market within 30 calendar days
  • 3. Receive Your $200 Rebate

Level 1 Rebate

Deposit $1,000 and get $100 Rebate
$ 100 Rebate
  • 3 Simple Steps
  • 1. Register Using The Link Below (Promo-Code: WEBREBATE)
  • 2. Deposit $1,000 and place one trade at any non-Austalian market within 30 calendar days
  • 3. Receive Your $100 Rebate

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex Securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Act Fast - Promotion Ends In
Click Here To Get Started
Act Fast - Promotion Ends In
Click Here For More Info